Showing results (151-160 of 162) with videos related to
Sort By:
Pageof 17
Optics Express|May 4, 2016
Graphene electrodes for adaptive liquid crystal contact lensesS Kaur, Y-J Kim, H Milton, et al.Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2000
The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitizationS Mukherjee, V V Gurevich, J C Jones, et al.The Journal of Biological Chemistry|August 11, 2001
Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cellsL M Salvador, Y Park, J Cottom, et al.Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.DNA and Cell Biology|July 6, 2000
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterizationJ E Piletz, T R Ivanov, J D Sharp, et al.Surgery|May 1, 1980
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary reportC A Hubay, O H Pearson, J S Marshall, et al.Cancer|December 15, 1980
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.Pageof 17